Home/Filings/4/0000899243-22-007014
4//SEC Filing

Bain Linda 4

Accession 0000899243-22-007014

CIK 0001659352other

Filed

Feb 17, 7:00 PM ET

Accepted

Feb 18, 4:05 PM ET

Size

8.1 KB

Accession

0000899243-22-007014

Insider Transaction Report

Form 4
Period: 2022-02-16
Bain Linda
Chief Financial Officer
Transactions
  • Award

    Stock Option (Right to Buy)

    2022-02-16+20,30020,300 total
    Exercise: $5.21Exp: 2032-02-15Common Stock (20,300 underlying)
  • Award

    Restricted Stock Units

    2022-02-16+30,45030,450 total
    Common Stock (30,450 underlying)
Footnotes (3)
  • [F1]25% of this option shall vest and become exercisable on February 16, 2023, with the remainder vesting in 12 equal quarterly installments thereafter.
  • [F2]Each restricted stock unit represents a contingent right to receive one share of common stock.
  • [F3]On February 16, 2022, the reporting person was granted 30,450 restricted stock units, vesting in four equal installments every six months beginning on the six month anniversary of the grant date.

Issuer

Codiak BioSciences, Inc.

CIK 0001659352

Entity typeother

Related Parties

1
  • filerCIK 0001578407

Filing Metadata

Form type
4
Filed
Feb 17, 7:00 PM ET
Accepted
Feb 18, 4:05 PM ET
Size
8.1 KB